Carnegie Mellon develops edible medical devices; NinePoint wins expanded FDA nod;

@FierceMedDev: FDA wants more data on Insuline's pump. Article | Follow @FierceMedDev

@MarkHFierce: Now this is just cool: Carnegie Mellon U. folks are developing med devices you would swallow and partially digest. More | Follow @MarkHFierce

 @DamianFierce: A spike in restructuring costs slashed Covidien's profits, despite a revenue jump. Story | Follow @DamianFierce

> The number of female angel investors grew in 2012, according to the Center for Venture Research at the University of New Hampshire. Story

> Carnegie Mellon University researchers are developing tiny electronic medical devices that a patient could swallow and partially digest after treatment is delivered. Story

> 2012 Fierce 15 winner Orthocare Innovations won a gold Edison Award for its Magellan foot and ankle device. More

> The European Society of Cardiology is urging physicians to take care when selecting patients for renal denervation, making sure their anatomy can handle the procedure. Article

> Deep brain stimulation device implants helped obese mice reduce their appetites, a new study by researchers at the University of Pennsylvania Perelman School of Medicine and elsewhere concludes. Story

> NinePoint Medical, another 2012 Fierce 15 winner, won an additional 510(k) clearance for its NvisionVLE imaging system, allowing it to be used to image esophageal microstructure. Release

> The FDA wants to regulate the use of internationally recognized symbols for medical device and biologic product labeling. Item

Biotech News

@FierceBiotech: NIH stops HIV vaccine trial after immunizations fail. Story | Follow @FierceBiotech

@JohnCFierce: So EU doesn't like Pfizer's Xeljanz at all. That's a blow. More | Follow @JohnCFierce

@RyanMFierce: Industry Voices: Time to Take Fecal Transplantation Seriously. Article | Follow @RyanMFierce

> Biotech startup hustles new Alzheimer's program to the clinic. News

> Johnson & Johnson, Evotec bask in Harvard's breaking diabetes discovery. Article

> Biotech Receptos trots out terms for $71M IPO. Item

> Theravance to split into two biotech groups as GSK drugs progress. More

Pharma News

@FiercePharma: Trending at FiercePharma.com: European regulators tag 100-plus drugs with 'black triangle. Article | Follow @FiercePharma

@EricPFierce: Ipsen warns of shortages of its orphan drug Increlex. Story | Follow @EricPFierce

> Docs call drugmakers 'profiteers' for costs of cancer meds. Story

> Pfizer appealing CHMP ruling on RA treatment Xeljanz. Report

> Humira carries AbbVie in its first quarter as standalone company. More

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.